Acute intermittent porphyria

Best Practice and Research: Clinical Gastroenterology

Volumn 19, Issue 2 SPEC. ISS., 2005, Pages 235-249

  Herrick, Ariane L ^a,c   McColl, Kenneth E L ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c Arthritis Research Campaign   (United Kingdom)

Author keywords

Acute intermittent porphyria; Delta aminolaevulinic acid; Haem; Porphobilinogen; Porphobilinogen deaminase; Porphyrin

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BILIRUBIN; BILIVERDIN; CHLORPROMAZINE; CYTOCHROME P450; DICLOFENAC; GLUCOSE; GONADORELIN; GRISEOFULVIN; HEME; HEME ARGINATE; HEME DERIVATIVE; HEME OXYGENASE; HEMIN; INFUSION FLUID; MORPHINE; OPIATE; PORPHOBILINOGEN DEAMINASE; PORPHOBILINOGEN SYNTHASE; PORPHYRIN; PROCHLORPERAZINE; PROPRANOLOL; PROTOPORPHYRIN TIN; STEROID HORMONE; TOBACCO SMOKE;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ALCOHOL CONSUMPTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CALORIC INTAKE; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE EXACERBATION; ENZYME ACTIVITY; ENZYME DEFECT; ENZYME SYNTHESIS; FATALITY; HUMAN; HYPERTENSION; HYPONATREMIA; MASS SCREENING; MOLECULAR BIOLOGY; NAUSEA AND VOMITING; NEUROTOXICITY; PATHOGENESIS; PHYSIOTHERAPY; PREMENSTRUAL SYNDROME; SEIZURE; TACHYCARDIA; TOTAL PARENTERAL NUTRITION;

EID: 17044380622     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2004.10.006     Document Type: Article

References (48)

1. P. Mustajoki R. Kauppinen L. Lannfelt et al. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland J Int Med 231 1992 389-395
2. M.N. Badminton & G.H. Elder Management of acute and cutaneous porphyrias Int J Clin Pract 56 2002 272-278
3. M.R. Moore K.E.L. McColl C. Rimington & A. Goldberg Disorders of Porphyrin Metabolism 1987 Plenum Publishing Corporation New York
4. Y. Nordmann & H. Puy Human hereditary hepatic porphyrias Clin Chim Acta 325 2002 17-37
5. J. Hultdin A. Schmauch A. Wikberg et al. Acute intermittent porphyria in childhood: A population-based study Acta Paediatr 92 2003 562-568
6. A. Goldberg Acute intermittent porphyria. A study of 50 cases Quart J Med 28 1959 183-209
7. J.A. Stein & D.P. Tschudy Acute intermittent porphyria - a clinical and biochemical study of 46 patients Medicine (Baltimore) 49 1970 1-16
8. A. Ridley The neuropathy of acute intermittent porphyria Quart J Med 38 1969 307-333
9. A.C. Yeung Laiwah R. Mactier K.E.L. McColl et al. Early-onset chronic renal failure as a complication of acute intermittent porphyria Quart J Med 205 1983 92-98
10. S.D. Whatley A.G. Roberts & G.H. Elder De-novo mutation and sporadic presentation of acute intermittent porphyria Lancet 346 1995 1007-1008
11. K.E.L. McColl M.R. Moore G.G. Thompson & A. Goldberg Screening for latent acute intermittent porphyria: The value of measuring both leucocyte δ-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities J Med Genet 19 1982 271-276
12. R. Kauppinen M. & von und zu Frauberg Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families Clin Chem 48 2002 1891-1900
13. J.M. Lamon B.C. Frykholm & D.P. Tschudy Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase J Med Genet 16 1979 134-139
14. P. Mustajoki Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria Ann Int Med 95 1981 162-166
15. H. Puy J.C. Deybach J. Lamoril et al. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria Am J Hum Genet 60 1997 1373-1383
16. R. Kauppinen S. Mutajoki H. Pihlaja et al. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene Hum Mol Genet 4 1995 215-222
17. B. Grandchamp Acute intermittent porphyria Sem Liver Dis 18 1998 17-24
18. N. Raich P.H. Romeo A. Dubart et al. Molecular cloning and complete primary sequence of human porphobilinogen deaminase Nucleic Acids Res 14 1986 5955-5968
19. C-H. Chen K.H. Astrin G. Lee et al. Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene J Clin Invest 94 1994 1927-1937
20. W.E. Schreiber A. Jamani & J.G. Armstrong Acute intermittent porphyria in a native north American family Am J Clin Pathol 103 1995 730-734
21. H. Puy U. Gross J.C. Deybach et al. Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria Hum Genet 103 1998 570-575
22. Y. Floderus P.M. Shoolingin-Jordan & P. Harper Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene Clin Genet 62 2002 288-297
23. A. Gregor X. Schneider-Yin U. Szlendak et al. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute imtermittent porphyria Hum Mutat 19 2002 310-314
24. B. Grandchamp H. de Verneuil C. Beaumont et al. Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene Eur J Biochem 162 1987 105-110
25. H.-W. Yoo C.A. Warner C.-H. Chen & R.J. Desnick Hydroxymethylbilane synthase: Complete genomic sequence and amplifiable polymorphisms in the human gene Genomics 15 1993 21-29
26. S. Sassa Diagnosis and therapy of acute intermittent porphyria Blood Rev 10 1996 53-58
27. Stokvis BJ. Over Twee Zeldsame Kleurstoffen in Urine Van Zicken. Amsterdam, Nederland: Tijdschr. Geneekunde; 1889, 13, 409-417
28. P.R. Ortiz de Mortellano & M.A. Correia Suicidal destruction of cytochrome P-450 during oxidative drug metabolism Annu Rev Pharmacol Toxicol 23 1983 481-503
29. C. Andersson E. Innala & T. Backstrom Acute intermittent porphyria in women: Clinical expression, use, and experience of exogenous sex hormones. A population-based study in northern Sweden J Int Med 254 2003 176-183
30. W.B. Seiden L.P. Kelly & R. Ali Acute intermittent porphyria assocated with ovarian stimulation. A case report J Reprod Med 48 2003 201-203
31. P.A. Rodgers & D.K. Stevenson Developmental biology of heme oxygenase Clin Perinatol 17 1990 275-291
32. T.L. Robert L. Varella & M.M. Meguid Nutrition management of acute intermittent porphyria Nutrition 10 1994 551-555
33. K.E.L. McColl G.G. Thompson M.R. Moore & A. Goldberg Acute ethanol ingestion and haem biosynthesis in healthy subjects Eur J Clin Invest 10 1980 107-112
34. G.Y.H. Lip K.E.L. McColl A. Goldberg & M.R. Moore Smoking and recurrent attacks of acute intermittent porphyria Br Med J 302 1991 507
35. M.J.W. Brennan R.C. Cantrill & S. Kramer Effect of δ-aminolaevulinic acid on GABA receptor binding in synaptic plasma membranes Int J Biochem 12 1980 833-835
36. R.L.P. Lindberg C. Porcher B. Grandchamp et al. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria Nat Genet 12 1996 195-199
37. S.B. Dover L. Plenderleith M.R. Moore & K.E.L. McColl Safety of general anaesthesia and surgery in acute hepatic porphyria Gut 35 1994 1112-1115
38. K.E. Anderson I.M. Spitz S. Sassa et al. Prevention of attacks of acute intermittent porphyria with a long-acting agonist of luteinizing-hormone releasing hormone N Eng J Med 311 1984 643-645
39. A.L. Herrick K.E.L. McColl A.M. Wallace et al. LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria Q J Med 75 1990 355-363
40. W.O. Tatum & S.B. Zachariah Gabapentin treatment of seizures in acute intermittent porphyria Neurology 45 1995 1216-1217
41. P. Mustajoki R. Tenhunen O. Tokola & G. Gothoni Haem arginate in the treatment of acute hepatic porphyria Br Med J 293 1986 538-539
42. P. Mustajoki R. Tenhunen C. Peirach & L. Volin Heme in the treatment of porphyrias and hematological disorders Semin Hematol 26 1989 1-9
43. H.L. Bonkovsky J.F. Healey A.N. Lourie & G.G. Gerron Intravenous heme-albumin in acute intermittent porphyria: Evidence for repletion of hepatic hemoproteins and regulatory heme pools Am J Gastroenterol 86 1991 1050-1056
44. P. Mustajoki & Y. Nordmann Early administration of heme arginate for acute porphyric attacks Arch Intern Med 153 1993 2004-2008
45. A.L. Herrick K.E.L. McColl M.R. Moore et al. Controlled trial of haem arginate in acute hepatic porphyria Lancet 1 1989 1295-1297
46. S.B. Dover M.R. Moore E.J. Fitzsimmons et al. Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria Gastroenterol 105 1993 500-506
47. A. Johannsson C. Moller & P. Harper Correction of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene delivery Mol Cell Biochem 250 2003 65-71
48. Z.F. Soonawalla T. Orug M.N. Badminston et al. Liver transplantation as a cure for acute intermittent porphyria Lancet 363 2004 705-706